PharVision Advisers’s O-I Glass OI Stock Holding History

PharVision Advisers’s Portfolio OI Stock Details OI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,871	Closed	-$470K	–	483
2025 Q4	$470K	Buy	+31,871	New	+$422K	0.24%	54

Other funds holding OI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's OI Position: Q1 2026 in Review

PharVision Advisers sold out of O-I Glass (OI) in Q1 2026, closing a stake of 31,871 shares — an estimated $470K sold.

PharVision Advisers first reported a position in OI in Q4 2025 and held it in 1 quarter. The position peaked at $470K in Q4 2025. 303 funds tracked by Wall St. Rank hold OI as of Q1 2026.

PharVision Advisers reported no remaining O-I Glass position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 31,871 O-I Glass shares in Q1 2026, an estimated $470K.
PharVision Advisers first reported a position in O-I Glass in Q4 2025 and held it in 1 quarter.
PharVision Advisers's O-I Glass position peaked at $470K in Q4 2025.
303 funds tracked by Wall St. Rank held O-I Glass as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.